When Too Much Fuel Breaks the Engine

Glycolytic Overload, Fatty Liver, and the Hidden Energy Crisis

For years, metabolic diseases like fatty liver have been framed as a simple problem of too many calories. Eat less sugar, burn more fat, and the problem should resolve.

But a new 2025 review in Clinical Science challenges this oversimplified view—and in doing so, quietly supports a deeper concept: disease emerges not just from excess intake, but from failure of metabolic resolution.

A new thesis: glycolytic overload, not just fat

In their review, “Molecular mechanisms of metabolic dysfunction–associated steatotic liver disease (MASLD)”, Rabbani and Thornalley propose a unifying mechanism behind fatty liver and its downstream consequences: glycolytic overload.

Their central argument is strikingly simple:

When glucose and fructose enter the liver faster than they can be safely processed, early glycolytic intermediates accumulate, triggering a cascade of maladaptive responses.

This overload occurs before fat builds up. Lipid accumulation, insulin resistance, and inflammation are secondary consequences, not the initiating problem.

Why glucose and fructose together are uniquely harmful

The review highlights a critical—and often missed—point:

• Glucose increases flux through hepatic glucokinase

• Fructose removes the natural braking system (GKRP) that normally restrains this pathway

Together, glucose and fructose remove metabolic speed limits. Carbon floods into the liver regardless of actual energy demand.

This explains why modern diets—rich in sweetened beverages, processed foods, and “liquid calories”—are especially potent drivers of metabolic disease, even when total calorie intake is not extreme.

From glycolytic overload to metabolic congestion

Once glycolysis is overloaded, several downstream effects follow:

• The TCA cycle becomes congested, not because it is broken, but because it is oversupplied

• Acetyl-CoA accumulates, losing its flexibility to switch between oxidation, signaling, and storage

• The liver diverts excess carbon into lipogenesis and storage as a protective outlet

• Mitochondria downshift oxidative phosphorylation (OXPHOS) to limit oxidative damage

Importantly, these changes are initially adaptive. They are attempts to protect the cell.

But when exposure is chronic, adaptation hardens into maladaptation.

Alignment with the ERM framework: abundance becomes malnutrition

This is where the study aligns powerfully with the Exposure-Related Malnutrition (ERM) framework.

ERM proposes that modern chronic diseases arise not from classic nutrient deficiency, but from bioenergetic mismatch:

• Plenty of fuel

• Impaired ability to convert that fuel into usable, flexible energy

In ERM terms:

• Glycolytic overload → TCA congestion

• TCA congestion → acetyl-CoA inflexibility

• Acetyl-CoA inflexibility → forced anabolic storage bias

• Persistent storage bias → impaired mitochondrial recovery and resilience

The result is a state of functional malnutrition: the body is overfed but underpowered.

This explains why patients with fatty liver, insulin resistance, or metabolic syndrome often report fatigue, brain fog, poor exercise tolerance, and slow recovery—despite “normal” or excessive caloric intake.

A key clinical insight: storage is not the enemy

One of the most important takeaways from both the review and the ERM framework is this:

Fat accumulation is not the primary pathology—it is a safety valve.

The real problem is loss of metabolic flexibility and recovery capacity.

Treating fatty liver by focusing only on fat reduction, weight loss, or calorie restriction risks missing the deeper issue: the metabolic system is jammed, not lazy.

Clinical implications: shifting from restriction to resolution

The review also points toward therapeutic strategies that fit naturally with ERM principles:

• Reducing combined glucose–fructose exposure, especially liquid sugars

• Supporting mitochondrial redox balance and recovery

• Restoring metabolic flexibility, not just suppressing pathways

• Using interventions that expand oxidative and recovery capacity, rather than forcing more suppression

Notably, the authors discuss Nrf2 activation as a way to divert excess glucose away from harmful pathways and reduce metabolic congestion—an approach that aligns with ERM’s emphasis on restoring adaptive capacity rather than imposing chronic restriction.

The bigger picture

This study reinforces a growing realization in metabolic medicine:

You’re not broken—you’re overloaded and unable to recover.

Modern metabolic disease is less about gluttony and more about systems pushed beyond their capacity to resolve stress.

By reframing fatty liver disease and insulin resistance as consequences of bioenergetic congestion, rather than moral failure or simple excess, we open the door to more humane, effective, and durable clinical strategies.

In short:

Glycolytic overload explains how abundance turns into dysfunction.ERM explains why that dysfunction feels like malnutrition.

Together, they point toward a future of care focused on restoring energy flow, resilience, and recovery—not just cutting calories.

Rabbani, N., & Thornalley, P. J. (2025). Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD): Functional analysis of glucose and fructose metabolism pathways. Clinical Science, 139(21), 1405–1429. https://doi.org/10.1042/CS20257727